■ PHYSICAL EXAMINATION
The patient is awake and alert.
Vital signs: Oral temperature 37.4˚C (99.3˚F), pulse 110 beats per minute, blood pressure 124/86 mm Hg (sitting and standing), respiratory rate 18 per minute, oxygen saturation by pulse oximetry while breathing room air 86% in the sitting position and 90% supine.
Head: Normocephalic, and no trauma is noted. Examination of the eyes shows xanthelasmata over the eyelids and mild icterus. Examination of the head, eyes, ears, nose, and throat is otherwise normal.
Neck: No stridor is heard. Lung auscultation: Bilateral rales are noted approximately one quarter of the way up both lungs; no bruits or wheezes. Cardiac examination: Tachycardia is noted, but no hepatojugular reflux or jugular venous distention. Heart tones are normal without an increased P 2 . No heaves, rubs, thrills, or murmurs are noted.
Abdominal examination: Mild ascites; the liver spans 15 cm, is palpable approximately 2 cm below the right costal margin, and is not pulsatile; a spleen tip is palpable below the left costal margin; no caput medusa.
Extremities: Traces of bilateral pedal edema and noteworthy clubbing of all digits.
Skin: Mild icterus, xanthelasma over the eyes, and spider telangiectasia on the trunk and chest. Multiple excoriations are noted, which are thought to be due to scratching.
Neurologic status: The patient is oriented to person, place, and time. There is no asterixis. The neurologic examination is nonfocal.
Laboratory tests
• White blood cell count 7.5 × 10 9 /L (normal 4-11) • Hemoglobin concentration 13. 
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Additional studies
Plain chest (posteroanterior) radiography shows a normal cardiac silhouette, subtly increased interstitial markings in both lung bases, no pulmonary nodules, and clear costophrenic angles.
Arterial blood gasses on room air (supine at rest): The correct answer is hepatopulmonary syndrome. The differential diagnosis for hypoxemia, generally defined as a widened alveolar-arterial gradient for age, is extensive, and only some of the possibilities are included in the list of answer choices above. Broadly, six mechanisms of hypoxemia must be considered. In the evaluation of hypoxemia, calculation of the alveolar-arterial oxygen gradient is important, because it helps to distinguish two of the mechanisms of hypoxemia associated with the normal alveolar-arterial oxygen gradient when adjusted for age (ie, hypoventilation and inhalation of gas with decreased FiO 2 ) from the other four causes, all of which are associated with an elevated age-specific alveolar-arterial oxygen gradient.
Our patient has the constellation of chronic liver disease, an elevated alveolararterial oxygen gradient (43 mm Hg, normal < 16 mm Hg for a 48-year-old), bilateral interstitial lung markings, and digital clubbing. Furthermore, she experiences dyspnea simply by standing upright (ie, platypnea). Given her presentation, this unusual symptom should cause the clinician to suspect a cause of worsened oxygenation due to assuming the upright posture.
Though the interstitial infiltrates in the setting of primary biliary cirrhosis raise the specter of interstitial lung disease (which can in fact complicate primary biliary cirrhosis and which is supported by the presence of rales), interstitial fibrosis would not be expected to cause platypnea. Rather, in the face of chronic liver disease and hypoxemia, platypnea should strongly suggest hepatopulmonary syn- T A B L E 1 drome. 1,2 At the same time, platypnea occurs in only a minority of these patients and is not pathognomonic for the syndrome, as it may accompany other conditions characterized by positional right-to-left shunting (eg, pulmonary arteriovenous malformations, patent foramen ovale with interatrial streaming of blood).
■ KEY FEATURES
Hepatopulmonary syndrome is characterized by the triad of liver disease, hypoxemia (defined by either an alveolar-arterial oxygen gradient exceeding 20 mm Hg or a PaO 2 on room air less than 70 mm Hg), and intrapulmonary vascular dilatations, which represent dilated pulmonary capillaries. 1,2 These dilatations are responsible for hypoxemia, proposed to be mediated by "diffusion-perfusion impairment," a combination of diffusion impairment and anatomic right-to-left shunt. Diffusionperfusion impairment shares features of anatomic right-to-left shunt and diffusion impairment in that inhalation of 100% oxygen causes a partial but incomplete normalization of the PaO 2 . In contrast, in pure anatomic right-to-left shunt, inhalation of 100% oxygen would not be expected to raise the PaO 2 , and in pure diffusion impairment, inhalation of pure oxygen might be expected to normalize the PaO 2 , at least at rest. The intrapulmonary vascular dilatations are engorged pulmonary capillaries. In contrast to the normal capillary diameter of approximately 8 µm, the pulmonary capillaries in hepatopulmonary syndrome have an enlarged diameter of up to approximately 100 µm. The result is that a red blood cell traversing the pulmonary capillary bed may transit FIGURE 1) . This phenomenon is worsened by the increased cardiac output that is characteristic of chronic liver disease, 3 which causes red cells to move through the pulmonary capillary bed more quickly than normal, allowing less time to equilibrate with any available oxygen.
The other answer choices above do not explain our patient's hypoxemia. Specifically, the increased interstitial markings on the chest radiograph could represent intrapulmonary vascular dilatations or interstitial fibrosis that accompanies primary biliary cirrhosis. The presence of rales on auscultation favors the latter. There is no history of an acute event to suggest pulmonary embolism. None of the drugs she is taking is likely to cause the subtle interstitial infiltrates found on her chest radiograph. The overall picture does not suggest congestive heart failure.
■ CASE CONTINUED
The patient undergoes measurement of arterial blood gasses while standing and at rest, breathing room air, with the following results: PaO 2 43 mm Hg, PaCO 2 The correct answer is all of the above. As noted before, shortness of breath on standing is called platypnea. Worsening of hypoxemia on standing up is called orthodeoxia, sometimes defined as either a 4-mm Hg fall in the PaO 2 on going from supine to standing or a 5% or greater fall in the PaO 2 . Notably, orthodeoxia is opposite to the normal physiologic changes in oxygenation on standing. Specifically, in normal people, oxygenation improves slightly on standing as ventilation-perfusion matching improves; perfusion to the better ventilated lung bases increases with gravity on standing up. In hepatopulmonary syndrome, pulmonary arteriovenous malformation, right-to-left interatrial streaming (eg, through a patent foramen ovale 4 or atrial septal defect, or via anomalous venous drainage), and anatomic right-to-left shunt can sometimes increase with upright posture. In hepatopulmonary syndrome, this occurs because the intrapulmonary vascular dilatations are characteristically more prominent at the lung bases. Standing up increases perfusion in the lung bases where the dilatations predominate, thereby worsening the anatomic shunt with a resultant widened alveolar-arterial oxygen gradient and decreased PaO 2 .
■ CONFIRMING THE DIAGNOSIS
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Which additional test can be used to confirm hepatopulmonary syndrome? ❑ Contrast-enhanced echocardiography (eg, with saline, indocyanine, or a modified gelatin contrast agent)
❑ Technetium Tc 99m pyrophosphate lung scan with detection over brain or abdominal organs ❑ Sampling arterial blood gas after the patient breathes 100% oxygen (shunt study)
❑ All of the above
❑ None of the above
The answer is all of the above. Each of these tests helps support the diagnosis of hepatopulmonary syndrome by demonstrating right-toleft anatomic shunt through the intrapulmonary vascular dilatations that characterize the syndrome.
Chronic liver disease, lung signs, digital clubbing, and platypnea point to hepatopulmonary syndrome
Saline-enhanced echocardiography is the most sensitive of these tests and is considered necessary for diagnosing hepatopulmonary syndrome. In this test, agitated saline is injected intravenously during echocardiography. The appearance of microbubbles in the left atrium or left ventricle is abnormal and is a sign of right-to-left shunt.
The timing of bubbles appearing in the left-sided chambers indicates whether the anatomic shunt is intracardiac (ie, due to an atrial septal defect or a ventricular septal defect) or intrapulmonary (eg, due to intrapulmonary vascular dilatations or arteriovenous malformations, as may be observed in hereditary hemorrhagic telangiectasia). Bubbles appearing within three cardiac cycles of the injection suggest intracardiac right-toleft shunt. Bubbles appearing four or more systoles after injection suggest intrapulmonary shunt, since the delayed appearance of bubbles reflects the time necessary for blood to transit through the pulmonary arteries. 3 The newest echocardiographic contrast agents (eg, perflutren) serve similar purposes, although they still have not been fully evaluated in this setting.
Technetium Tc 99m testing
Saline-enhanced echocardiography is highly sensitive for hepatopulmonary syndrome but lacks specificity because it can be abnormal in the absence of hypoxemia (which is one of the diagnostic criteria for the syndrome). Technetium Tc 99m lung scanning is more specific but less sensitive in detecting this syndrome.
In this test, the technetium Tc 99m macroaggregated albumin particles, which are normally trapped within the lung during a conventional lung scan and therefore are visualized within the lung parenchyma, can pass through the pulmonary circulation and be trapped in organs such as the brain, liver, kidney, and spleen. By counting the particles detected outside the chest, one can calculate the percent of shunt present.
Other options
Finally, a shunt study done with the patient breathing pure oxygen can be useful in detecting anatomic right-to-left shunt; however, as with the lung scan, it does not indicate if the site is intracardiac or intrapulmonary. Thus, this test is perhaps the least useful of the three in evaluating patients with hepatopulmonary syndrome. Furthermore, shunt studies can underestimate the degree of anatomic shunt in patients with the hyperdynamic circulation (and narrowed arteriovenous oxygen content difference) of chronic liver disease. 5 Hepatopulmonary syndrome is characterized hemodynamically by a state of low vascular resistance and high cardiac output. Invasive functional evaluation such as rightheart catheterization is generally not needed in the evaluation of this condition.
Pulmonary angiography is also rarely needed in these patients and should be reserved only for those with so-called type II hepatopulmonary syndrome, characterized by large intrapulmonary vascular dilatations. These patients may benefit from catheterization and selective embolization therapy of the markedly dilated vessels, which account for most of the anatomic shunt. 6, 7 Overall, the diagnostic evaluation of a patient with hepatopulmonary syndrome must begin with clinical suspicion based on the setting of chronic liver disease and symptoms, most commonly dyspnea, followed by measuring the room-air arterial blood gasses (perhaps ideally with the patient standing, to maximize any anatomic shunt). If the alveolar-arterial oxygen gradient is widened, confirmation of the diagnosis of the syndrome can be sought with saline-enhanced echocardiography. Lung scanning is more specific but less sensitive than saline echocardiography for hepatopulmonary syndrome
■ TREATMENT AND RESOLUTION
As recently as 1988, severe hypoxemia was considered a strong contraindication to orthotopic liver transplantation, because of the risks of surgery for hypoxemic patients and early observations that hepatopulmonary syndrome and hypoxemia persisted after transplantation. However, subsequent observations discounted these concerns and showed that oxygenation could normalize and that shunt could reverse following orthotopic transplantation in patients with this syndrome. 2, 8, 9 Another argument in favor of transplantation was that oxygenation could worsen over time in untreated patients, even if liver dysfunction was stable.
Although no randomized controlled studies have evaluated the role of orthotopic liver transplantation in hepatopulmonary syndrome, several observational studies have reported postoperative improvements in oxygenation, albeit with persistently impaired diffusing capacity. In a recent study 10 that compared the long-term outcomes of 61 patients with the syndrome who underwent transplantation vs 77 control patients who did not undergo transplantation, transplant recipients had a significant survival benefit overall, although the death rate was higher in those with a preoperative PaO 2 of less than 50 mm Hg.
Overall, complete resolution of the syndrome has been noted in a large number of patients who have undergone orthotopic liver transplantation. Thus, in contrast to earlier views, transplantation is considered the therapy of choice for severe hepatopulmonary syndrome, especially in pediatric patients. Moreover, in children, living hepatic lobar transplantation has been shown to be successful.
Prognostic indicators
While we still lack a specific predictor of posttransplantation response, post-transplantation morbidity has been higher in patients whose preoperative hypoxemia and shunt fraction (on technetium Tc 99m lung scanning) were worse. 11, 12 Considering the available data about response of this syndrome to liver transplantation, the European Respiratory Society Task Force on Pulmonary-Hepatic Vascular Diseases has strongly recommended transplantation if the patient's PaO 2 is between 50 and 60 mm Hg. For those with a PaO 2 less than 50 mm Hg, the recommendation is to individualize therapy. 13 ■ MANY TREATMENTS INEFFECTIVE; SOME MAY ALLEVIATE SYMPTOMS
Drugs
Besides liver transplantation, many drug treatments for this syndrome have been explored, most without proof of clinical effectiveness. [14] [15] [16] [17] Nonsteroidal anti-inflammatory drugs, 18 beta blockers, and corticosteroids have been tried without significant clinical impact.
Nondrug treatments
Nonpharmacologic treatments other than liver transplantation have included transjugular intrahepatic portosystemic shunts, [19] [20] [21] [22] [23] [24] venacavoplasty, 25, 26 and, in patients with discrete and large intrapulmonary dilatations, coil embolization of the dilatations. 7, 27, 28 Though anecdotal reports suggest these interventions might be effective, the sparse experience precludes firm recommendations. Garlic (allium sativum) has been anecdotally reported to improve gas exchange in these patients. 29 Nitric oxide inhibitors have been shown to improve gas exchange in these patients. Increasing evidence suggests that nitric oxide mediates the characteristic intrapulmonary vasodilatation. [30] [31] [32] Schenk et al 33 showed that methylene blue, a nitric oxide synthase inhibitor, is associated with short-lived improvement in oxygenation in these patients. Although this study offers pathophysiologic insights, it has limited clinical impact in that methylene blue is available for short-lived intravenous infusion but is not a long-term therapy. 33, 34 Overall, practical clinical management of these patients involves serial assessment of clinical symptoms and oxygenation, consideration of coil embolization in selected patients, and forthright discussion and consideration of liver transplantation for appropriate patients wishing to undertake this option. 
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